StockNASDAQ · US · USDIndustrials · Consulting Services
$SBC
SBC Medical Group Holdings Inc
SBC Medical Group Holdings operates a single-segment management services business focused primarily on aesthetic clinics in Japan owned and operated by medical corporations and other franchisees. It supports franchisee clinics with advertising and marketing, staff recruitment and training, bookings, procurement and resale of medical supplies and cosmetic products, clinic facilities, IT solutions, customer rewards programs, and licensing of medical technologies and trademarks. It also provides management and operational support to medical institutions through MB career lounge. As of December 31, 2025, SBC provides management services to 237 franchisee treatment centers in Japan, including 5 independently operated clinics under separate franchise arrangements. Through subsidiaries, it operates 21 treatment centers in Singapore and 1 treatment center in Vietnam under the SBC brand. Its brands include Shonan Beauty Clinic and, in Singapore, The Chelsea Clinics, Gangnam Laser Clinic, SkinGo! and Family clinics. SBC is headquartered in Irvine, California, and has offices in Tokyo, Japan.
SBC Medical reported Q3 2026 revenue growth of 35% to $59M and net income growth of 22% to $16M, with adjusted EBITDA up 66% to $28M. Shares fell 12% post-announcement. The company expanded its clinic network and is investing in AI and longevity initiatives.
SBC Medical Group Holdings reported Q3 2026 revenue of $59M, up 35% YoY, with net income of $16M (up 22%) and adjusted EBITDA of $28M (up 66%). The company attributed growth to service fee revisions and new clinic openings, expanding its network to 293 locations. CEO Yoshiyuki Aikawa highlighted investments in AI and technology to improve profitability and announced plans for international expansion.
SBC Medical Group Holdings Inc (SBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results Revenue Up 35%, Net Income Attributable to SBC Medical Up 22%, and Adjusted EBITDA 1 Up 66% Year-over-Year; Net Income Margin of 27% and Adjusted EBITDA Margin of 47% — Previously Announced Servi
via TradingView
SBC sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 20 news stories mentioning SBC (SBC Medical Group Holdings Inc). Coverage has skewed bullish: 18 bullish, 2 neutral, and 0 bearish.
Recent SBC coverage spans earnings, financial news and corporate actions.
What's driving SBC
Despite strong growth metrics, the stock fell sharply, implying investors focused on margin/earnings quality, guidance expectations, or valuation rather than top-line acceleration.
The alliance and capital investment are likely to be viewed as a positive step toward scaling SBC’s clinic operations systems with AI-enabled productivity gains.
The split mechanically increases share count and is paired with higher expected total distributions, which can support near-term investor demand while leaving per-share economics adjusted.
AlphAI scores every news story that mentions SBC with an AI model for sentiment and relevance, and aggregates insider trades from SBC Medical Group Holdings Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.
SBC Medical reported Q3 2026 revenue growth of 35% to $59M and net income growth of 22% to $16M, with adjusted EBITDA up 66% to $28M. Shares fell 12% post-announcement. The company expanded its clinic network and is investing in AI and longevity initiatives.
SBC Medical Group Holdings reported Q3 2026 revenue of $59M, up 35% YoY, with net income of $16M (up 22%) and adjusted EBITDA of $28M (up 66%). The company attributed growth to service fee revisions and new clinic openings, expanding its network to 293 locations. CEO Yoshiyuki Aikawa highlighted investments in AI and technology to improve profitability and announced plans for international expansion.
SBC Medical Group Holdings Inc (SBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results Revenue Up 35%, Net Income Attributable to SBC Medical Up 22%, and Adjusted EBITDA 1 Up 66% Year-over-Year; Net Income Margin of 27% and Adjusted EBITDA Margin of 47% — Previously Announced Servi
SBC Medical (Nasdaq: SBC) invested ¥600 million in AtomicSoftware, forming a capital and business alliance. They will co-develop AI features for clinic management, starting with physician documentation support, to enhance productivity and profitability. Medicalforce, AtomicSoftware's platform used by 800+ clinics in Japan, will be integrated into SBC Medical's systems.
Brompton Split Banc Corp. (SBC) announced a stock split of its class A shares, with shareholders receiving 10 additional shares for every 100 held, effective November 12, 2026. Trading on an ex-split basis begins November 10, 2026. The split is expected to increase total distributions by approximately 10%. The fund invests in six major Canadian banks and has delivered a 21.6% annual return over the last 10 years, outperforming relevant indices.
SBC Medical Group Holdings Inc. (Nasdaq: SBC) is developing a DNA test to measure biological age using DNA methylation analysis. The test aims to provide insights into physical health beyond chronological age, with development led by subsidiary SBC AI Longevity Innovation Inc. SBC shares fell 1.4% to $5.46, with a market cap of $562 million.
Emerging Growth Research released an updated quarterly report on SBC Medical Group Holdings Inc. (NASDAQ:SBC), highlighting 13% YoY revenue growth to $49.2M in Q2:26, improved profitability, AI-driven initiatives, and global expansion. The company reported $185M in cash and $38M in debt, with a Debt/Book Equity ratio of 14%.
SBC Medical Group reported a 32% EBITDA surge in Q2, with Gorilla Clinic's transaction value up 19% YoY to $62M. The company is expanding non-aesthetic healthcare, using AI for efficiency, and pursuing M&A. It expects $15M in annual service-fee increases. SBC is also advancing U.S. and Southeast Asia expansion, with plans for a longevity center in Japan. The company has $184M in cash for growth and M&A, aiming for steady EPS growth.
SBC Medical Group Holdings (NASDAQ: SBC) reported Q2FY26 revenue of $49.2M, up 13% YoY, and operating profit growth of 30%. The company attributed the growth to franchise fee normalization and the inclusion of Waqoo operations. SBC has $185M in cash and $38M in debt, with plans for AI integration and global expansion.
Emerging Growth Research released an updated Q2:26 report on SBC Medical Group Holdings Inc. (NASDAQ:SBC), highlighting 13% revenue growth to $49.2M, 30% operating profit increase, AI-driven initiatives, and global expansion. SBC has $185M in cash and $38M in debt. The report is company-sponsored, with EGR disclosing a $25,000 payment from SBC.